Japan Inbound Capital Intelligence · Filings & Activist Monitor
New foreign filers in small caps: one engagement buyer at an IPO, two patient accumulators, and AVI at 19.16% of Wacom
Zennor Asset Management LLP, a London LLP founded in 2002, took a new 6.27% of Oliver.
Sources: EDINET 大量保有報告書 S100Z3GY (Zennor, Oliver), filed 2026-09-28; EDINET S100Z3CY (Integral, Oliver), filed 2026-09-28; EDINET S100Z46M (TADRANA, Kondotec), filed 2026-09-28; EDINET S100Z3YX (Tempered, Findex), filed 2026-09-28; EDINET S100Z2KJ (AVI, Wacom), filed 2026-09-24; Companies House (Zennor); Nikkei (Wacom AGM), 2026-07-01
Oliver (619A): a PE exit, not a take-private set-up. Zennor Asset Management LLP, a London LLP founded in 2002, took a new 6.27% of Oliver. It bought 4.80% off-market at ¥305 on 8 September, then 1.47% on market on 16 September. Oliver is a re-IPO. Integral took it private in 2021 and re-listed it on the TSE Standard market on 16 September 2026. The offering sold only existing shares, from Integral's funds, at ¥305. Zennor's 4.80% at the offer price on pricing day is, on our reading, its IPO allocation. Integral's group still reports 18.77%. But Nomura holds a greenshoe (an underwriter's option to buy extra shares from the seller) over 11,115,000 of those shares, exercisable to 14 October. If Nomura exercises in full, Integral falls to about 7.65%. Integral also agreed a 180-day lock-up (a promise not to sell) from listing.
Zennor's purpose says it may propose on governance and capital efficiency, while the important-proposal field reads "none". It is FCA-authorised and runs Japan-focused funds. Oliver plans a payout ratio of about 70% for FY12/2026, stepping down to at least 50% from FY12/2027.
Kondotec (7438) and Findex (3649): accumulators, not campaigners. TADRANA Management und Asset GmbH, based in Vienna, Austria, lifted Kondotec to 8.05%, its fourth filing, with a pure-investment purpose. Its last two steps were off-market blocks, part-funded by a ¥976m loan from a Vienna private foundation. Fidelity reports 9.90% of the same company jointly. Tempered Investment Management, an SEC-registered adviser in North Vancouver, lifted Findex to 6.09% with pension-fund money and no proposal intent.
Wacom (6727). Asset Value Investors reached 19.16%, adding about a point a step since July. Its filing says it has proposed a 65% dividend payout target. At the June AGM, all AVI proposals failed. The motion to remove the CEO won 24.61% support and AVI's director nominee 43.41%; the CEO's re-election passed with 64.30%. AVI already holds 28.98% of Sharingtechnology, which MBK Partners bid to take private on 9 September.
Also filed: Nippon Active Value Fund with Dalton Investments lifted Ebara Jitsugyo to 12.69% jointly. Arcus Investment lifted Nihon Hospice to 6.09% with a passive purpose.
Position Signal. Only one of the three new filers carries engagement language, so "a new wave of small-cap activists" overstates it. The pattern is quieter: patient foreign money concentrating registers. Kondotec now has two foreign holders at about 18% combined. That matters in any future tender or buyback, even without an engagement flag [S]. At Wacom, 20% is an accounting line. A holder of 20% or more of voting rights must treat the company as an associate. On our reading, that is unlikely to bind a fund manager. The line that changes how AVI can buy is 30%. Since 1 May 2026, crossing 30% requires a tender offer, including through on-market buying. The June vote shows 35.7% of shares voted did not back the CEO, which suggests AVI's 2027 campaign starts from a stronger base unless Wacom moves on payout [S].
How to act: Oliver: watch for Nomura's greenshoe notice and an Integral change report by 14 October; the lock-up ends about mid-March 2027. Integral's remaining block is the supply an investor wanting size would buy. Wacom: AVI can keep buying on market below 30% without a tender; check whether Wacom adopts a payout target before the 2027 proxy season.
Disclaimer: Japan Inbound Capital Intelligence is published for general information and education only. It is not investment advice, and it is not an offer, solicitation or recommendation to buy, sell or hold any financial instrument, nor an invitation to engage in any investment activity. Nothing in it takes account of any reader's circumstances, objectives or needs. Figures and sources are believed accurate at the dates shown, but completeness and continuing accuracy are not guaranteed. Take your own professional advice before acting on anything here.